Back to Search
Start Over
Phase II neoadjuvant study evaluating capivasertib plus fulvestrant vs fulvestrant in patients with primary high-risk lobular breast cancer- LOBSTER.
- Source :
- Senologie; Jun2024, Vol. 21 Issue 2, pe19-e20, 2p
- Publication Year :
- 2024
Details
- Language :
- German
- ISSN :
- 16116453
- Volume :
- 21
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- Senologie
- Publication Type :
- Academic Journal
- Accession number :
- 177069106
- Full Text :
- https://doi.org/10.1055/s-0044-1786109